These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 17112309

  • 1. Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.
    Bressler R.
    Geriatrics; 2006 Nov; 61(11):12-8. PubMed ID: 17112309
    [Abstract] [Full Text] [Related]

  • 2. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [Abstract] [Full Text] [Related]

  • 3. [Grapefruit juice and drugs: a hazardous combination?].
    Lohezic-Le Devehat F, Marigny K, Doucet M, Javaudin L.
    Therapie; 2002 Mar; 57(5):432-45. PubMed ID: 12611197
    [Abstract] [Full Text] [Related]

  • 4. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
    Bailey DG, Dresser GK, Bend JR.
    Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
    [Abstract] [Full Text] [Related]

  • 5. [Grapefruit juice: potential drug interaction].
    Palumbo G, Bacchi S, Palumbo P, Primavera LG, Sponta AM.
    Clin Ter; 2005 Jun; 156(3):97-103. PubMed ID: 16048029
    [Abstract] [Full Text] [Related]

  • 6. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM, Paine MF, Stewart PW, Watkins PB.
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation.
    Wagner C, Thelen K, Willmann S, Selen A, Dressman JB.
    J Pharm Sci; 2013 Sep; 102(9):3205-19. PubMed ID: 23696038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK, Kim RB, Bailey DG.
    Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of grapefruit juice on the pharmacokinetics of sildenafil.
    Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta J, Schreiner P, Sörgel F, Fuhr U.
    Clin Pharmacol Ther; 2002 Jan; 71(1):21-9. PubMed ID: 11823754
    [Abstract] [Full Text] [Related]

  • 19. Prediction of the extent and variation of grapefruit juice-drug interactions from the pharmacokinetic profile in the absence of grapefruit juice.
    Kogure N, Akiyoshi T, Imaoka A, Ohtani H.
    Biopharm Drug Dispos; 2014 Oct; 35(7):373-81. PubMed ID: 24898424
    [Abstract] [Full Text] [Related]

  • 20. Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome P450 3A4.
    Tanaka S, Uchida S, Miyakawa S, Inui N, Takeuchi K, Watanabe H, Namiki N.
    Biol Pharm Bull; 2013 Oct; 36(12):1936-41. PubMed ID: 24292052
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.